Activation of NF-κB in immune cells results in the expression and production of multiple pro-inflammatory cytokines, including TNFα, IL-1, IL-6, IL-17 and IL-23, which promote cancer development in multiple mouse models [37, 45, 46, 47, 48, 49]. Here, NFKB1 is linked to cancer.